Metronidazole Tablets, USP, 500 mg, packaged in a) 10-count tablets per bottle (NDC 54868-0158-3); b) 14-count tablets per bottle (NDC 54868-0158-1); c) 20-count tablets per bottle (NDC 54868-0158-5); d) 21-count tablets per bottle (NDC 54868-0158-0); e) 30-count tablets per bottle (NDC 54868-0158-8), Rx only, Mfg. By: Pliva Krakow Pharma. Comp., Krakow, Poland; Repacked & distributed by: Physicians Total Care, Inc., Tulsa, OK 74146.

Failed Tablet/Capsule Specifications: Some tablets had the potential to not conform to weight specifications.

Recall #: D-547-2013
Affected scope: 25230 tablets: a) 190 bottles, b) 743 bottles, c) 293 bottles, d) 8 bottles, e) 230 bottles
Initiated: April 6, 2011

Compiled from official public sources by the publisher. · Updated September 2026

Physicians Total Care, Inc. recalled Metronidazole Tablets, USP, 500 mg, packaged in a) 10-count tablets per bottle (NDC 54868… - a moderate-severity action.

Metronidazole Tablets, USP, 500 mg, packaged in a) 10-count tablets per bottle (NDC 54868… was recalled by Physicians Total Care, Inc. in June 12, 2013. Reason: Failed Tablet/Capsule Specifications: Some tablets had the potential to not conform to weight specifications.. Check the official notice for the remedy. Verify recall #D-547-2013 with the FDA Drug before acting.

The recall

Physicians Total Care, Inc. issued this moderate-severity FDA Drug recall-Failed Tablet/Capsule Specifications: Some tablets had the potential to not conform to weight specifications..

Moderate
severity level: Class II
classification: June 12, 2013
reported

Sourced from official FDA Drug enforcement records. Verify recall #D-547-2013 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.

Recall Insight

This recall's affected scope, documented in the Recall Profile below, stays within a single-region or limited-distribution footprint. Distribution scope (see Distribution below) directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

Within the same product category the archive holds 6 closely related recalls, 6 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.

Where this agency-classified recall sits among FDA Class I/II/III notices

Of 88,244 recalls with an agency hazard classification, 19,068 are high severity, 64,652 moderate, and 4,524 low. A further 16,179 CPSC/NHTSA recalls have no agency class and are excluded from this split. This recall is classified moderate severity.

Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.

Product description

Metronidazole Tablets, USP, 500 mg, packaged in a) 10-count tablets per bottle (NDC 54868-0158-3); b) 14-count tablets per bottle (NDC 54868-0158-1); c) 20-count tablets per bottle (NDC 54868-0158-5); d) 21-count tablets per bottle (NDC 54868-0158-0); e) 30-count tablets per bottle (NDC 54868-0158-8), Rx only, Mfg. By: Pliva Krakow Pharma. Comp., Krakow, Poland; Repacked & distributed by: Physicians Total Care, Inc., Tulsa, OK 74146.

Reason for recall

Failed Tablet/Capsule Specifications: Some tablets had the potential to not conform to weight specifications.

Recall Profile

Structured summary of the FDA Drug recall record
Attribute	Value
Agency	U.S. Food and Drug Administration
Severity class	Moderate (Class II)
Status	Terminated
Recall number	D-547-2013
Date reported	June 12, 2013
Date initiated	April 6, 2011
Recalling firm	Physicians Total Care, Inc.
Firm location	Tulsa, OK
Affected scope	25230 tablets: a) 190 bottles, b) 743 bottles, c) 293 bottles, d) 8 bottles, e) 230 bottles
Distribution	Nationwide

Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.

What to do with this recall

Match your product against the recall record, then act on the agency remedy.

Check the recall number (D-547-2013) and product description against the item you own. Search the archive
Confirm the current status with FDA Drug before acting, recall details can be updated.
Follow the documented remedy (refund, replacement, repair, or disposal) rather than general advice. What to do next

This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.

Frequently Asked Questions

What product was recalled? ▼

Why was this product recalled? ▼

Failed Tablet/Capsule Specifications: Some tablets had the potential to not conform to weight specifications.

Which agency issued this recall? ▼

This recall was issued by the FDA Drug on June 12, 2013. Severity: Moderate. Recall number: D-547-2013.

Where was the recalled product distributed? ▼

Distribution: Nationwide.

Should I stop using a recalled medication or medical device? ▼

Do not stop using a recalled medication or device without consulting your healthcare provider first, as abruptly discontinuing treatment could pose its own health risks. Your doctor can advise on alternatives or whether the recall applies to your specific product lot. Check the recall number and lot information against your product packaging.

Nationwide recalls with similar severity or category timing

Drug and device notices outside this firm and state, matched by severity timing and product category.

Similar severity · nearest report date

Same archive severity grade (Moderate), closest by report date among other firms and states.

Salsa Cycles Recalls Bicycle Forks Due to… 2013-06-12 Diazepam Injection, USP 5 mg/mL, 10 mL, M… 2013-06-12 DOBUTamine in 5% Dextrose Injection, USP,… 2013-06-12 AMBI 15DM/100GFN/5PEH, Antitussive, Expec… 2013-06-12

Similar Drugs & Medications · nearest report date

Same product category, closest by report date among other firms and states (deduped against the severity set).

AMBI 40PSE/400GFN, 100 tablet bottle, OTC… 2013-06-12 Methotrexate 25mg/mL Injectable, 10 mL vi… 2013-06-12 Avastin 1.25 mg/0.05 mL Injectable, 4 mL … 2013-06-12 Baclofen 500 mcg/mL Injectable, 22 mL via… 2013-06-12

Compare this recall with Kian Pee Wan Capsules, 30-count bottles → · All Drugs & Medications recalls

This recall: FDA Drug, reported June 12, 2013. Severity classes follow each agency's own taxonomy; related-recall context is computed across the full archive.

Methodology · Corrections · Archive as of August 2026